dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· June 16, 2026

Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.

View original at globenewswire.com
Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc. MIAMI, June 17, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs, peneraju dalam dana dagangan bursa bertema dan berleveraj, hari ini mengumumkan bahawa Cboe BZX Exchange, Inc…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • SpaceX risks include new or unproven technology programs such as Starship, next-generation Starlink satellites, and orbital AI initiatives

    60% confidence
  • Cboe BZX Exchange has approved the resumption of trading in SPCL shares following the temporary suspension initiated by the Exchange on June 12, 2026

    60% confidence
  • The SpaceX IPO constitutes a Material Space Event as defined in the amended Prospectus, which will cause the fund to hold all or a significant portion of its portfolio in instruments providing exposure to SpaceX shares

    60% confidence
  • Throughout the suspension period, the underlying portfolio assets remained secure and were unaffected by the trading suspension imposed by the Exchange

    60% confidence
  • Defiance pioneered single-stock leveraged ETFs, allowing investors to take amplified positions in high-potential companies with precise leveraged exposure without opening a margin account

    60% confidence
  • For periods longer than one day, the fund's performance will be the result of compounded daily returns, which will almost certainly differ from 200% of the Target Portfolio's return over the same period

    60% confidence
  • The derivatives market (swaps, options) for SpaceX as a newly listed company may be limited, illiquid, highly volatile, expensive, or unavailable, which could increase tracking error or prevent the fund from achieving its investment objective

    60% confidence
  • SpaceX is expected to be a controlled company with voting power concentrated in founder Elon Musk through Class B common shares carrying 10 votes per share

    60% confidence
  • SPCL's investment in SpaceX exposure relies on derivatives (swap agreements and listed option contracts) rather than directly holding underlying securities

    60% confidence
  • The fund is intended for knowledgeable investors who understand the implications of seeking leveraged daily (2X) investment results and are prepared to monitor their portfolios frequently; it is not suitable for investors who do not intend to actively monitor and manage their portfolios

    60% confidence
  • The fund's investment results following a rebalancing in response to a Material Space Event may differ materially from prior results, and the fund may temporarily deviate from its targeted daily exposure level

    60% confidence
  • SPCL seeks daily investment results equal to 200% of the daily performance of its Target Portfolio

    60% confidence
  • An investor could lose the entire value of their principal investment in a single trading day

    60% confidence

Data points we hold from this source

Elon Musk · parameter count10 votes_per_Class_B_share
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.: Source | Via News | fr.via.news